$BENF

Fletcher Derek L. purchased $5K of BENF

Fletcher Derek L. (See Remarks) purchased 4,717 shares of Beneficient (BENF) at $1.06 on 2026-09-15.

Original reporting
SEC EDGAR · Fletcher Derek L.
Published Sep 17, 2026, 8:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 17, 2026, 9:12 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$BENF
Neutral
medium confidence
Mentioned
$BENF
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BENFNeutralLow
01

Why it matters

The filing provides a fresh data point on insider sentiment but the transaction size is modest, limiting actionable trading opportunities.

02

Market read

A routine insider purchase with low materiality; may be noted by investors tracking insider activity but unlikely to affect broader market sentiment.

03

Timing

post‑market 2026‑09‑15

Relevance 4/10Novelty 4/10Timing: post‑market 2026‑09‑15

Background

Beneficient (BENF) is a micro‑cap listed on a US exchange. The filing reports a direct insider purchase by an officer/director.

Company-level read

Ticker impact

$BENFNeutralMedium confidence
Context

Officer/director Fletcher Derek L. bought 4,717 shares of Beneficient at $1.06 each, increasing his stake to 5,336 shares.

Expected impact

Minimal price movement expected; may provide slight support if investors view insider buying positively.

Evidence & confidence

The $5K purchase is a routine Form 4 filing for a micro‑cap; while it adds a positive signal, the amount is too small to drive significant price change.

Key entities

  • Beneficient

    Issuer of the Form 4 filing.

  • Fletcher Derek L.

    Officer and director of Beneficient who purchased shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AKAMHighAI 8/10

Akamai's $11.6 Billion Anthropic Cloud Deal, TD SYNNEX's 9.87% Q3 Earnings Plunge Headline Transformative Week for US Stocks

Akamai Technologies (AKAM) announced an $11.6 billion cloud services agreement with Anthropic PBC, lifting shares 14%. The deal includes warrants for Anthropic to acquire up to 5% of Akamai's equity and could expand by $9 billion. The agreement shifts Akamai's focus to AI cloud infrastructure and provides significant revenue visibility.

$BENFMedAI 8/10

Beneficient Announces Strategy to Eliminate HCLP Debt and Heppner Equity Interests

Beneficient (BENF) announced a strategy to eliminate $130M in disputed debt and convert $850M in equity interests held by former CEO Brad Heppner, who was convicted of fraud. The plan aims to resolve all agreements with Heppner before his October sentencing, potentially eliminating substantial debt and unlocking value for shareholders. The company is pursuing a consensual resolution but is prepared to litigate if necessary.

$BENFMedAI 8/10

Beneficient Announces Strategy to Eliminate HCLP Debt and Heppner Equity Interests

Beneficient (BENF) filed an SEC Form 8-K — Regulation FD Disclosure. Exhibit 99.1 Beneficient Announces Strategy to Eliminate HCLP Debt and Heppner Equity Interests DALLAS, September 23, 2026 (GLOBE NEWSWIRE) — Beneficient (NASDAQ: BENF) (the “Company”), a technology-enabled platform providing exit opportunities and primary capital solutions and r

$BENFMedAI 8/10

Beneficient Reports First Quarter Fiscal 2027 Results

Beneficient (NASDAQ: BENF) reported fiscal 2027 first-quarter results ended June 30, 2026. The company entered its first collateral management services engagement with a Texas state-chartered bank and closed primary capital commitments totaling over $16 million. Investments with fair value rose to $212.5 million. Operating expenses fell 84.3% to $12.5 million, including a $1.8 million loss-contingency accrual.